We in-depth established a monograph containing the prognostic factors, such as KIF2C expression, age, and radiation therapy, to supply a quantitative base to forecast the possibility of one-year, three-year, and five-year OS in glioma patients for clinicians (Figure 8(c)). Here, KIF2C is linked to glioma.